The number of financings among life sciences companies in the TechBio sector increased from Q3 2023, stabilizing in H1 2024. During the period Q3 2023 – Q3 2024, a total of $6bn was raised, with the second quarter of 2024 contributing the largest share at $2.2bn, just over a third of the total. (See Exhibit 1, 2)
TechBio Investment Snapshot: Funding, Alliances And Collaboration
Data provided by Biomedtracker show that data-driven methodologies within R&D are propelling life sciences to unprecedented advancements. It is making drug development faster, more efficient and more personalized.
